Cargando…

Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials

Background: Generalized anxiety disorder (GAD) is one of the most common psychiatric disorders associated with substantial dysfunction and socioeconomic burden. Pharmacotherapy is the first choice for GAD. Remission [Hamilton Anxiety Scale (HAM-A) score ≤7] is regarded as a crucial treatment goal fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Wenqiang, Deng, Huiyuan, Wan, Jie, Zhou, Yilu, Zhou, Yan, Song, Bihui, Wang, Xiuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7741609/ https://www.ncbi.nlm.nih.gov/pubmed/33343351 http://dx.doi.org/10.3389/fphar.2020.580858

Ejemplares similares

Efficacy of Brahmi vati in generalised anxiety disorder – Randomized double blind comparative clinical trial
por: Khot, Siddhi G., et al.
Publicado: (2022)

A CONTROLLED DOUBLE BLIND CLINICAL TRIAL OF BUSPIRONE AND DIAZEPAM IN GENERALISED ANXIETY DISORDER
por: Shah, L.P., et al.
Publicado: (1990)

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
por: Carroll, F. Ivy, et al.
Publicado: (2018)

Time to 12-month remission and treatment failure for generalised and unclassified epilepsy
por: Bonnett, Laura J, et al.
Publicado: (2014)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
por: Zhao, Xue, et al.
Publicado: (2023)

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study
por: Huang, Kai, et al.
Publicado: (2022)

Role of antioxidants in generalised anxiety disorder and depression
por: Gautam, Medhavi, et al.
Publicado: (2012)

Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline
por: Newman, Joseph V., et al.
Publicado: (2018)

A Phase I, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Tolerance of Oil Palm Phenolics (OPP) in Healthy Volunteers
por: Muhammad Ismail Tadj, Nur Balqis, et al.
Publicado: (2022)

Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
por: Cheng, Junlin, et al.
Publicado: (2023)

Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial
por: Xu, Xuan, et al.
Publicado: (2023)

Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data
por: Sauzet, Odile, et al.
Publicado: (2022)

Generalised Anxiety Disorder and Depression: Contemporary Treatment Approaches
por: Goodwin, Guy M., et al.
Publicado: (2021)

Traditional Chinese Medicine Combined With Chemotherapy and Cetuximab or Bevacizumab for Metastatic Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Liu, Ningning, et al.
Publicado: (2020)

Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
por: Li, Jiansheng, et al.
Publicado: (2022)

Anti-Wrinkle Efficacy of Edible Bird’s Nest Extract: A Randomized, Double-Blind, Placebo-Controlled, Comparative Study
por: Kim, Hyung Mook, et al.
Publicado: (2022)

Vitamin D Enhances Efficacy of Oral Nifedipine in Treating Preeclampsia with Severe Features: A Double Blinded, Placebo-Controlled and Randomized Clinical Trial
por: Shi, Dan-Dan, et al.
Publicado: (2017)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study
por: Gu, Si-Chun, et al.
Publicado: (2022)

Management of generalised anxiety disorder in adults: summary of NICE guidance
por: Kendall, Tim, et al.
Publicado: (2011)

The relationships between perfectionism, pathological worry and generalised anxiety disorder
por: Handley, Alicia K, et al.
Publicado: (2014)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Revisiting Treatment Options for Depressed Patients with Generalised Anxiety Disorder
por: Goodwin, Guy M.
Publicado: (2021)

Threat reversal learning and avoidance habits in generalised anxiety disorder
por: Roberts, Clark, et al.
Publicado: (2022)

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
por: Li, Shanshan, et al.
Publicado: (2023)

A double-blind, randomized, placebo-controlled, single-center clinical trial of jiaotaiwan for the treatment of insomnia symptoms caused by disharmony of the heart and kidney
por: Xia, Nengzhi, et al.
Publicado: (2022)

Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Ni, Wenjing, et al.
Publicado: (2023)

Efficacy and safety of remimazolam besylate in bronchoscopy for adults: A multicenter, randomized, double-blind, positive-controlled clinical study
por: Zhou, Ying-Yong, et al.
Publicado: (2022)

Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of the QX002N anti-IL-17 Monoclonal Antibody: A Phase I, Randomized, Double-Blind, Single Ascending Dose Study in Healthy Chinese Volunteers
por: Wu, Min, et al.
Publicado: (2022)

A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects
por: Huang, Kai, et al.
Publicado: (2021)

A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Efficacy and Mechanism of Buyang Huanwu Decoction in Patients With Ischemic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Trial Combined With Proteomic Analysis
por: Zhu, Mingjun, et al.
Publicado: (2022)

Corrigendum: A Chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial
por: Wan, Yingying, et al.
Publicado: (2022)

Etanercept induces remission of polyarteritis nodosa: a case report
por: Capuozzo, Maurizio, et al.
Publicado: (2014)

Comparative Study Between Fosaprepitant and Palonosetron in the Prophylaxis of Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy: Prospective, Randomized and Double-Blind Study
por: Braga, Estêvão Luiz Carvalho, et al.
Publicado: (2022)

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
por: Jain, Mamta K., et al.
Publicado: (2022)

Against the Stream: Generalised anxiety disorder (GAD) – a redundant diagnosis
por: Tyrer, Peter
Publicado: (2018)

Psychometric properties of the Generalised Anxiety Disorder Dimensional Scale in an Australian sample
por: Groves, David, et al.
Publicado: (2023)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
por: Jacobi, Henrike, et al.
Publicado: (2023)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma
por: Lv, Yubao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3dni7p8ou7h4rboi1bhkcukqpb